Riskpilot← Back to searchSign inGet full accessEvidens AB
ABActiveOrg 5566020607Rosviksgatan 18Activities of psychologists and psychotherapists, except medical doctors · NACE 8693Est. 20001 employees
Revenue 2024
SEK 0
EBITDA margin
—
+59% vs 2023
Equity ratio
56.8%
Financial strength
Net profit 2024
SEK -2K
+33% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -82K | +59% |
| Net profit | SEK -2K | +33% |
| Total assets | SEK 877K | -4% |
| Equity | SEK 498K | +0% |
| Employees | 1 | — |
Legal name
Evidens AB
Org number
5566020607
Legal form
Aktiebolag
NACE code
8693 · Activities of psychologists and psychotherapists, except medical doctors
Founded
30 november 2000
Share capital
SEK 280 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva utbildning, handledning och konsultationer inom kognitiva psykoterapi även som idka därmed förenlig verksamhet.
Address
Rosviksgatan 18
Email
carina.nilsson@evidens4u.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 716 | 3 390 | 161 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −1 022 | −17 | −281 | −202 | −82 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −1 022 | −17 | −281 | −202 | −82 |
| Net financials | −1 | — | — | −1 | — |
| Profit before tax | 3 603 | −17 | −281 | −3 | −2 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 3 603 | −17 | −281 | −3 | −2 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 511 | 4 547 | 1 142 | 915 | 877 |
| Equity | 4 120 | 4 103 | 502 | 499 | 498 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 391 | 444 | 641 | 416 | 379 |
| Total debt | 3 391 | 444 | 641 | 416 | 379 |
EBITDA margin
-8200000.0%
This company
15.8%
Market median
-51898834% vs market
20202024
Equity ratio
56.8%
This company
38.2%
Market median
+49% vs market
20202024
Return on equity
-0.4%
This company
18.4%
Market median
-102% vs market
20202024
Net profit margin
-200000.0%
This company
8.1%
Market median
-2469236% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.76×
This company
0.62×
Market median
+23% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JT Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
ÅC Chief Auditor | Chief Auditor | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Enebackens Forsknings och Utvecklings Aktiebolag
Evidens AB Board members of Evidens AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Tommy Nordén | Chief Executive Officer | 0 companies |
| Åsa Cecilia Önfelt | Chief Auditor | 0 companies |
| Carina Eva Margareta Nilsson Nordén | Deputy Board Member | 0 companies |